Cargando…
Not one, but many: developing a multi-indication pricing model for medicines in Belgium
Back ground: Current pricing and reimbursement models that focus on one indication at a time are not suited to address the market access of multi-indication medicines. Therefore, the aim of this study is to co-create with Belgian stakeholders a multi-indication pricing model and procedural pathway,...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575738/ https://www.ncbi.nlm.nih.gov/pubmed/37841908 http://dx.doi.org/10.3389/fphar.2023.1199253 |